Andrew J. Novak Net Worth

The estimated Net Worth of Andrew Novak is at least $603 dollars as of 17 May 2019. Mr Novak owns over 5,400 units of Novan Inc stock worth over $603 and over the last 6 years he sold NOVN stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Novak NOVN stock SEC Form 4 insiders trading

Mr has made over 1 trades of the Novan Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 5,400 units of NOVN stock worth $7,938 on 17 May 2019.

The largest trade he's ever made was buying 5,400 units of Novan Inc stock on 17 May 2019 worth over $7,938. On average, Mr trades about 771 units every 0 days since 2018. As of 17 May 2019 he still owns at least 6,700 units of Novan Inc stock.

You can see the complete history of Mr Novak stock trades at the bottom of the page.

Mr. Andrew J. Novak biography

Andrew J. Novak is the VP of Accounting & Bus. Operations and Chief Accounting Officer at Novan Inc.

What's Mr Novak's mailing address?

Andrew's mailing address filed with the SEC is C/O NOVAN, INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703.

Insiders trading at Novan Inc

Over the last 8 years, insiders at Novan Inc have traded over $72,487 worth of Novan Inc stock and bought 1,476,993 units worth $9,839,419 . The most active insiders traders include John W Palmour, Robert J Keegan, and Life Sciences Holdings Ltd .... On average, Novan Inc executives and independent directors trade stock every 70 days with the average trade being worth of $4,566. The most recent stock trade was executed by Machelle Sanders on 27 June 2023, trading 11,553 units of NOVN stock currently worth $4,737.

What does Novan Inc do?

novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.

Complete history of Mr Novak stock trades at Novan Inc

Novan Inc executives and stock owners

Novan Inc executives and other stock owners filed with the SEC include:

• Paula Brown Stafford M.P.H.,
  Pres, CEO & Chairwoman
• Paula Brown Stafford,
  Pres, CEO & Chairwoman
• Paula Stafford,
  Chairman of the Board, President, Chief Executive Officer
• John M. Gay CPA,
  CFO & Corp. Sec.
• John M. Gay,
  CFO & Corp. Sec.
• John Gay,
  Chief Financial Officer, Vice President - Finance, Corporate Controller, Corporate Secretary
• Robert Ingram,
  Independent Director
• Jenene Thomas,
  Investors Relation
• Machelle Sanders,
  Independent Director
• John Palmour,
  Independent Director
• Robert Keegan,
  Independent Director
• James Bierman,
  Director
• W. Geer,
  Lead Independent Director
• Stanley Hollenbach BS, J.D.,
  Sr. VP of R&D
• John A. Donofrio Jr.,
  Exec. VP, COO & Pres of EPI Health
• Dr. Tomoko Maeda-Chubachi M.B.A., M.D., Ph.D.,
  Chief Medical Officer
• Brian M. Johnson,
  Chief Commercial Officer
• Elizabeth Messersmith,
  Sr. VP & Chief Devel. Officer
• Stanley Hollenbach BS,J.D.,
  Sr. VP of R&D
• Cole Ikkala,
  Director of Investor Relations, Communications & Bus. Devel.
• Dr. Carri Geer,
  Sr. VP & CTO
• Andrew J. Novak,
  VP of Accounting & Bus. Operations and Chief Accounting Officer
• Brian M. Johnson,
  Chief Commercial Officer
• Life Sciences Holdings Ltd ...,
  
• Sean Murphy,
  Director
• Nathan Stasko,
  President & CSO, Director
• G. Kelly Martin,
  Chief Executive Officer
• William L Hodges,
  Interim Chief Financial Office
• M. Joyce Rico,
  Chief Medical Officer
• F Nealt.D.H. One, Llct.D.H....,
  
• A. Donofrio John,
  EVP, Chief Operating Officer
• Eugene Sun,
  Director
• Jeff N Hunter,
  EVP & Chief Business Officer
• Steven D Skolsky,
  Director